Citalopram hydrobromide and Asterixis - a phase IV clinical study of FDA data

Summary:

Asterixis is reported as a side effect among people who take Citalopram hydrobromide (citalopram hydrobromide), especially for people who are male, 60+ old, also take Pantoprazole Sodium, and have Dyspnea.

The phase IV clinical study analyzes which people have Asterixis when taking Citalopram hydrobromide. It is created by eHealthMe based on reports of 32,819 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,880 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Asterixis?

Asterixis (flapping tremor, or liver flap) is found to be associated with 198 drugs and 458 conditions by eHealthMe. Check the latest studies of Asterixis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

32,819 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 12 people (0.04%) have Asterixis.

Could Citalopram hydrobromide cause Asterixis?

Among these 12 people:

What is the gender of people who have Asterixis when taking Citalopram hydrobromide? *

female: 50 %
male: 50 %

What is the age of people who have Asterixis when taking Citalopram hydrobromide? *

What are other drugs people take besides Citalopram hydrobromide? *

What are other side effects people have besides Asterixis? *

Fatigue (feeling of tiredness): 8 people, 66.67%
Drowsiness: 8 people, 66.67%
Blood Potassium Decreased: 5 people, 41.67%
Confusion: 5 people, 41.67%
Blood Glucose Increased: 5 people, 41.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 41.67%
Weakness: 5 people, 41.67%
Blood Sodium Decreased: 5 people, 41.67%
Motormental Retardation (a slowing-down of thought and a reduction of physical work): 4 people, 33.33%
High Blood Pressure: 4 people, 33.33%

What are the existing conditions these people have? *

Wheezing (a high-pitched whistling sound made while you breath): 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Vascular Encephalopathy (vascular disorder or disease of the brain): 1 person, 8.33%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 8.33%
Pain In Extremity: 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Hepatitis C: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and have Asterixis?

- Check whether Asterixis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Citalopram hydrobromide:

Citalopram hydrobromide (36,880 reports)

Asterixis treatments and more:

Asterixis (1,271 reports)

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Asterixis:

Asterixis (198 drugs)

Browse all the conditions that are associated with Asterixis:

Asterixis (458 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.